Raise closed, search for fresh raises on Seedstage
Seal Beach, CA
Scaling a doctor-founded wellness brand delivering sugar-free hydration and inflammation relief through enzyme-powered drink mixes.
- Doctor-founded and science-backed: Created by Harvard-trained doctors using decades of clinical research.
- Strong early traction: Over 2M packets sold and $1.5M in cumulative revenue.
- High customer retention: 68% 12-month retention rate and 45% of revenue from subscriptions.
- Retail expansion underway: Currently in 2,000 stores and being reviewed by Kroger, Target, and Whole Foods.
- Positioned for acquisition: Operating in a hot category with recent $B exits like Poppi and Liquid I.V.
Bala Enzyme is a science-backed wellness brand offering the first doctor-formulated drink mix that targets both inflammation and dehydration without using sugar or artificial ingredients. Founded by Harvard-trained doctors with decades of clinical experience, the brand’s proprietary EnzymX Recovery Accelerator® (patent pending) blends potent plant enzymes, electrolytes, and amino acids into a convenient powder mix. With over two million packets sold and $1.5 million in cumulative revenue, Bala has already built a loyal customer base of over 100,000, boasting a 68% retention rate—more than twice the industry average. Online sales remain strong, with Amazon revenue up 69% year-over-year, and 45% of online revenue coming from subscriptions.
Now poised to expand into large retail outlets, Bala is already present in 2,000 stores and in active review with major chains such as Kroger, Target, Publix, and Whole Foods Market. The brand is also preparing to launch new product formats, including gummies and capsules, and new enzyme-based formulas targeting immune and brain health. Positioned within the $180 billion functional hydration market, Bala benefits from growing consumer awareness about the impacts of chronic inflammation and dehydration. Backed by CPG veterans from Vita Coco, Coca-Cola, and Poppi, and with a clear acquisition pathway in a sector known for billion-dollar exits, Bala aims to scale rapidly and become a household name in functional wellness.
Company Info
Bala Enzyme is a science-backed wellness drink brand addressing inflammation and dehydration through a doctor-formulated, plant-based hydration mix.
Bala Enzyme is a doctor-founded wellness brand offering a patent-pending, plant-based hydration and recovery drink mix designed to combat both inflammation and dehydration. Formulated with natural ingredients like bromelain, papain, curcumin, and electrolytes, Bala targets health-conscious consumers looking for effective, clean alternatives to synthetic supplements and sugary sports drinks. With over two million packets sold and a growing base of 100,000+ customers, Bala has gained significant traction in the functional hydration market, boasting a 68% 12-month retention rate and 69% year-over-year Amazon sales growth.
Founded by Harvard and Boston University-trained doctors with clinical backgrounds in enzyme therapy, Bala has earned endorsements from beverage veterans with ties to Vita Coco, Coca-Cola, and Poppi. The company is currently available in 2,000 retail stores, with expansion efforts underway in major chains like Kroger, Target, and Whole Foods Market. With cumulative revenue of $1.5 million and 45% of digital revenue from subscriptions, Bala plans to scale its retail presence, launch new formats like capsules and gummies, and introduce products focused on immune and brain health. Positioned in a hot acquisition market, Bala offers investors a stake in a fast-growing, science-driven wellness brand.





